Azenta, Inc.
General ticker "AZTA" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.6B (TTM average)
Azenta, Inc. follows the US Stock Market performance with the rate: 38.9%.
Estimated limits based on current volatility of 2.1%: low 24.24$, high 25.59$
Factors to consider:
- Total employees count: 3300 (-5.7%) as of 2024
- US accounted for 55.8% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Geopolitical risks, Regulatory and compliance, Currency fluctuations, Customer concentration and demand forecasting, Supply chain disruptions
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [24.26$, 38.54$]
- 2026-09-30 to 2027-09-30 estimated range: [27.11$, 41.80$]
Financial Metrics affecting the AZTA estimates:
- Positive: with PPE of 56.3 at the end of fiscal year the price was neutral
- Positive: -4.75 < Operating profit margin, % of -1.86
- Positive: Shareholder equity ratio, % of 83.85 > 64.29
- Negative: Investing cash flow per share per price, % of -6.63 <= -4.43
- Positive: 0.01 < Operating cash flow per share per price, % of 5.29
- Positive: -9.07 < Industry operating profit margin (median), % of -3.21
Short-term AZTA quotes
Long-term AZTA plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $665.07MM | $573.45MM | $593.82MM |
| Operating Expenses | $738.20MM | $603.43MM | $605.09MM |
| Operating Income | $-73.13MM | $-29.98MM | $-11.27MM |
| Non-Operating Income | $42.69MM | $10.86MM | $4.12MM |
| R&D Expense | $33.96MM | $31.52MM | $30.39MM |
| Income(Loss) | $-30.43MM | $-19.12MM | $-7.14MM |
| Taxes | $-17.55MM | $5.24MM | $-31.60MM |
| Other Income(Loss) | $-1.37MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-14.26MM | $-164.90MM | $-55.76MM |
| Stockholders Equity | $2,534.50MM | $1,768.97MM | $1,726.99MM |
| Inventory | $128.20MM | $115.26MM | $74.96MM |
| Assets | $2,885.72MM | $2,100.04MM | $2,059.58MM |
| Operating Cash Flow | $5.83MM | $49.74MM | $72.18MM |
| Capital expenditure | $39.44MM | $37.39MM | $33.86MM |
| Investing Cash Flow | $431.38MM | $224.74MM | $-90.46MM |
| Financing Cash Flow | $-840.46MM | $-659.21MM | $-9.59MM |
| Earnings Per Share** | $-0.22 | $-3.10 | $-1.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.